INTERNATIONAL PATENT: ITABMED BIOPHARMACEUTICAL (SHANGHAI) CO., LTD., 天劢源和生物医药（上海）有限公司 FILES APPLICATION FOR "MULTI-SPECIFIC ANTIGEN-BINDING PROTEIN TARGETING BCMA, CD19 AND CD3 AND USE THEREOF"

GENEVA, Aug. 17 -- ITABMED BIOPHARMACEUTICAL (SHANGHAI) CO., LTD. (Room 203, Building C9, No. 2555 Xiupu RoadPudong New Area, Shanghai 201315), 天劢源和生物医药（上海）有限公司 (中国上海市浦东新区秀浦路2555号C9栋203室) filed a patent application (PCT/CN2025/076236) for "MULTI-SPECIFIC ANTIGEN-BINDING PROTEIN TARGETING BCMA, CD19 AND CD3 AND USE THEREOF" on Feb 07, 2025. With publication no. WO/2025/168059, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent...